Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

BACKGROUND: Neutropenia is a common adverse reaction of chemotherapy. We assessed whether chemotherapy-induced neutropenia could be a predictor of survival for patients with non-small-cell lung cancer (NSCLC). METHODS: A total of 387 chemotherapy-naïve patients who received chemotherapy (vinorelbine...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishida, Y, Kawahara, M, Teramukai, S, Kubota, K, Komuta, K, Minato, K, Mio, T, Fujita, Y, Yonei, T, Nakano, K, Tsuboi, M, Shibata, K, Atagi, S, Kawaguchi, T, Furuse, K, Fukushima, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778518/
https://www.ncbi.nlm.nih.gov/pubmed/19862000
http://dx.doi.org/10.1038/sj.bjc.6605348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778518/
https://www.ncbi.nlm.nih.gov/pubmed/19862000
http://dx.doi.org/10.1038/sj.bjc.6605348

Ejemplares similares